7-Chloro-6-Nitro-4-Hydroxyquinazoline CAS 53449-14-2 Puritas >99.0% (HPLC)

Description:

Nomen: 7-Chloro-6-Nitro-4-Hydroxyquinazoline

CAS: 53449-14-2

Puritas: >99.0% (HPLC)

Aspectus: lux Yellow ut lux Brown pulveris

Afatinib Dimaleate (CAS: 850140-73-7)

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum 7-Chloro-6-Nitro-4-Hydroxyquinazoline
Synonyma 7-Chloro-4-Hydroxy-6-Nitroquinazoline;7-Chloro-6-Nitro-4-Quinazolinol;7-Chloro-6-Nitro-4-Quinazolinone;7-Chloro-6-Nitro-4(3H)-Quinazolinone;7-Chloro-6-Nitro-3,4-Dihydroquinazolin-4-unum;7-Chloro-6-Nitroquinazolin-4(3H)-one
CAS Number 53449-14-2
CATTUS Number RF-PI2030
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C8H4ClN3O3
M. Pondus 225.59
Sensibilitas Calor Sensitiva
Solubilitas Leviter solutum in Dimethylformamide
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Lumen Yellow ut lux Brown Pulvis
Lepidium sativum (HPLC) Retention Time of Sample should Matches with Standard
Puritas / Analysis Methodus >99.0% (HPLC)
Liquescens punctum 300.0~303.0℃
Aqua Content (KF) <0.50%
Residere in Ignition <0.30%
immunditia 1 <0.50% (7-Chloro-4-Hydroxyquinazoline CAS: 31374-18-2)
immunditia 2 <0.50% (5,7-Dichloro-4[1H]quinazolinone)
immunditia 3 <1.00% (7-Chloro-8-Nitro-4[1H]quinazolinone)
Alia immunitas <0.20%
Totalis immunditias <1.00%
Metalla gravia (ut Pb) <20ppm
Infrared Imaginis Conformat ut Structure
Proton NMR Spectrum Proton NMR Spectrum
Test Standard Enterprise Standard
Consuetudinem Medium Afatinib, Afatinib Dimaleate

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

1

FAQ:

Applicatio:

7-Chloro-6-Nitro-4-Hydroxyquinazoline (CAS: 53449-14-2) intermedius est Afatinib Dimaleate (CAS: 850140-73-7).Afatinib irreversibilis est familia interclusorum ErbB qui informationes transmissionis supprimunt et vias maiores impeditas quae in incremento et divisione cellae cancri implicantur.Quia ErbB familiae informationes transductionis mechanismi possunt per plures homodimersos et heterodimeros Urguere, simultanea inhibitio plurium membrorum familiarium ErbB (ut EGFR, HER2, ErbB3 et ErbB4) efficaciter interrumpens informationes transductionem amni possunt.Afatinib tractare certum genus cancri pulmonis (cancri pulmonis non parvae) quae in alias partes corporis diffusa est.Genus medicamentorum quod inhibitores kinasi notum est.Is incrementa cancer cellulis retardando vel impediendo operatur.interdum in quibusdam tumoribus quibusdam (epiderma receptor-EGFR) alligat.

Epistulam tuam hic scribe et mitte nobis